Vapotherm Inc, a global leader in high-flow oxygen therapy products, earned one of the top awards for its exhibit at the American Association for Respiratory Care (AARC)’s 54th Annual Convention and Exhibition in Anaheim, Calif.

Second place honors went to Vapotherm for its exhibit featuring Precision Flow™, the first high-flow therapy device to integrate humidification, gas blending, flow control, and full alarm functionality into a single device for the delivery of nasal-cannula-inspired gases.  510(k) clearance for the Precision Flow was received from the US Food and Drug Administration in August.

“The AARC Conference is the premier research and professional meeting for the respiratory therapy field,  We are proud that the AARC recognized our work,” said Kevin Thibodeau, Vapotherm’s executive vice     president of sales and marketing. 
Vapotherm is a privately held manufacturer of respiratory care devices for hospitals and home care use based in Stevensville, Maryland.  The company develops noninvasive technologies for respiratory therapy, especially for the treatment of chronic lung disease and acute breathing disorders.

(Pictured from left: Timothy R. Myers (AARC), Ann Hannam (Vapotherm, Inc.), Bill Niland (Vapotherm, Inc.) and Woody Hines (Vapotherm, Inc.)